← Back to Search

Continuous Glucose Monitoring for Gastroparesis in Diabetes

N/A
Recruiting
Led By Samita Garg, MD
Research Sponsored by Samita Garg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No episodes of diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic Status (HHS), or hypoglycemia in the past 3 months requiring ER visit or hospitalization
In patients with gastroparesis, documented delayed gastric emptying on scintigraphy and/or wireless motility capsule (Smart Pill) as defined by greater than 10% retention at 4 hours or greater than 4-hour gastric transit time (GTT) in the past five years
Must not have
Advanced chronic kidney disease (serum creatinine of >2 mg/dL or estimated glomerular filtration rate (eGFR) <30mL/min/1.73m² using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula
Advanced and significant cardiovascular disease or unstable angina
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 2 - day 5 (-3/+6 days), and visit 4 - day 25 (-7/+3 days)
Awards & highlights

Summary

This trial compares glucose control in people with diabetes, with and without gastroparesis, to see if one group fares better.

Who is the study for?
This trial is for adults over 18 with type 1 or type 2 diabetes and a recent Hemoglobin A1c ≤11%. It's specifically for those who've had diabetes for at least a year without severe incidents in the past three months. Participants should have gastroparesis symptoms for three months, confirmed by tests, and must use a smartphone compatible with the LibreView App.
What is being tested?
The study is testing how well the FreeStyle Libre 3 sensor monitors blood sugar levels in patients with both diabetes and gastroparesis compared to diabetic patients without gastroparesis. It also looks at how nutritional drinks affect these metrics.
What are the potential side effects?
Potential side effects may include skin irritation from the glucose sensor adhesive, inaccurate readings leading to mismanagement of insulin doses, and possible digestive discomfort from the nutritional drink.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't had severe diabetes complications requiring hospital visits in the last 3 months.
Select...
My tests show slow stomach emptying in the last 5 years.
Select...
I have been diagnosed with diabetes (type 1 or 2) for at least a year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My kidney function is severely reduced.
Select...
I have severe heart disease or unstable chest pain.
Select...
I have had surgery on my stomach.
Select...
I have been diagnosed with celiac disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 2 - day 5 (-3/+6 days), and visit 4 - day 25 (-7/+3 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 2 - day 5 (-3/+6 days), and visit 4 - day 25 (-7/+3 days) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Metrics of Glucose Variability
Time Above Range (TAR)
Time Below Range (TBR)
+2 more
Secondary study objectives
Hyperglycemia episodes
Hypoglycemia episodes
Other study objectives
GCSI questionnaire
GIQLI questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patients with type 1 or type 2 diabetes and gastroparesisExperimental Treatment2 Interventions
Both groups will have the same intervention. * FreeStyle Libre 3 sensor for Continuous Glucose Monitoring. * Balanced nutritional drink (Boost plus 8 ounces/237 mL) for a standardized meal challenge.
Group II: Patients with type 1 or type 2 diabetes without gastroparesisActive Control2 Interventions
Both groups will have the same intervention. * FreeStyle Libre 3 sensor for Continuous Glucose Monitoring. * Balanced nutritional drink (Boost plus 8 ounces/237 mL) for a standardized meal challenge

Find a Location

Who is running the clinical trial?

Samita GargLead Sponsor
Samita Garg, MDPrincipal InvestigatorThe Cleveland Clinic
~30 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top